Global epidemiology of tuberculosis

Clinics in Chest Medicine

Volumn 26, Issue 2, 2005, Pages 167-182

  Maher, Dermot ^a   Raviglione, Mario ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CAUSE OF DEATH; CHEMOTHERAPY; CLINICAL OBSERVATION; DIAGNOSTIC TEST; DISEASE CONTROL; EPIDEMIC; GOVERNMENT; HEALTH PROGRAM; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MEASUREMENT; MICROSCOPY; MONITORING; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RECORDING; REGISTER; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS; SPUTUM SMEAR; STANDARDIZATION; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 17044394716     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.02.009     Document Type: Review

References (51)

1. World Health Organization 47th World Health Assembly: provisional agenda item 19. Tuberculosis programme-Progress report by the Director-General. Document WHA47/1994/A47/12 1994 World Health Organization Geneva (Switzerland)
2. World Health Organization WHO declares tuberculosis a global emergency [press release] April 23, 1993 World Health Organization Geneva (Switzerland)
3. World Health Organization Stop TB. An expanded DOTS framework for effective tuberculosis control. Document WHO/CDS/TB/2002.297 2002 World Health Organization Geneva (Switzerland)
4. D. Maher, and M. Mikulencak What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Document WHO/CDS/CPC/TB/99. 270 1999 World Health Organization Geneva (Switzerland)
5. D. Maher, K. Floyd, and M. Raviglione A strategic framework to decrease the burden of TB/HIV 2002 World Health Organization Geneva (Switzerland)
6. World Health Organization DOTS-plus and the Green Light Committee Document WHO/CDS/TB/2000.283 2000 World Health Organization Geneva (Switzerland)
7. World Health Organization Global tuberculosis control: surveillance, planning, financing. WHO report 2004. Document WHO/HTM/TB/2004.331 2004 World Health Organization Geneva (Switzerland)
8. M.F. Cantwell, D.E. Snider Jr, and G.M. Cauthen Epidemiology of tuberculosis in the United States, 1985 through 1992 JAMA 272 1994 535 539
9. M.C. Raviglione, P. Sudre, and H.L. Rieder Secular trends of tuberculosis in Western Europe Bull World Health Organ 71 1993 297 306
10. H.L. Rieder, J.-P. Zellwegger, and M.C. Raviglione Tuberculosis control in Europe and international migration. Report of European Task Force Eur Respir J 7 1994 1545 1553
11. M.C. Raviglione, P. Sudre, and K. Esteves Tuberculosis-Western Europe, 1974-1991 MMWR Morb Mortal Wkly Rep 42 1993 628 631
12. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe: quarterly report no. 46, 30 June 1995
13. M.C. Raviglione, D. Snider, and A. Kochi Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic JAMA 273 3 1995 220 226
14. World Health Organization Treatment of tuberculosis: guidelines for national programmes. 3rd edition. Document WHO/CDS/TB/2003.313 2003 World Health Organization Geneva (Switzerland)
15. E.L. Corbett, C.J. Watt, and N. Walker The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 2003 1009 1021
16. C. Dye, S. Scheele, P. Dolin for the WHO Global Surveillance and Monitoring Project Global burden of tuberculosis: estimated incidence, prevalence and mortality by country JAMA 282 1999 677 686
17. C.J.L. Murray, K. Styblo, and A. Rouillon Tuberculosis in developing countries: burden, intervention and cost Bull Int Union Tuberc Lung Dis 65 1990 6 24
18. M.C. Raviglione, and F. Luelmo Update on the global epidemiology of tuberculosis Curr Issues Public Health 2 1996 192 197
19. H.L. Rieder, G.M. Cauthen, and G.W. Comstock Epidemiology of tuberculosis in the United States Epidemiol Rev 11 1989 79 98
20. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2004 report on the global AIDS epidemic 2004 UNAIDS Geneva (Switzerland)
21. T.A. Kenyon, M.J. Mwasekaga, and R. Huebner Low levels of drug-resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana Int J Tuberc Lung Dis 3 1999 4 11
22. A.D. Harries, L. Nyong'Onya Mbewe, and F.M. Salaniponi Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi Lancet 347 1996 807 809
23. United Nations Statistics Division Millennium Indicators Database Available at: http://unstats.un.org/unsd/mi/mi_goals.asp Accessed August 4, 2004
24. K. Buhl, and J. Nyboe Epidemiological basis of tuberculosis eradication. Changes in the mortality of Danish tuberculosis patients since 1925 Bull World Health Organ 37 1967 907 925
25. B.C. Thompson Survival rates in pulmonary tuberculosis BMJ 2 1943 721
26. Second East African/British Medical Research Council Kenya Tuberculosis Survey follow-up 1979 Tuberculosis in Kenya: follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. An East African and British Medical Research Council co-operative investigation Tubercle 60 1979 125 149
27. Y.D. Mukadi, D. Maher, and A.D. Harries Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa AIDS 15 2001 143 152
28. A.D. Harries, N.J. Hargreaves, and J. Kemp Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1 Lancet 357 2001 1519 1523
29. J. Crofton, P. Chaulet, and D. Maher Guidelines for the management of drug-resistant tuberculosis. Document WHO/TB/1996.210 1997 World Health Organization Geneva (Switzerland)
30. World Health Organization Anti-tuberculosis drug resistance in the world. Report number 3. The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance 1999-2002 2004 World Health Organization Geneva (Switzerland)
31. World Health Organization Guidelines for establishing DOTS-plus pilot projects for the management of multidrug-resistant tuberculosis. Document WHO/CDS/TB/2000.278 2000 World Health Organization Geneva (Switzerland)
32. World Health Organization Guidelines for social mobilization: a human rights approach to tuberculosis. Document WHO/CDS/TB/2001.9 2001 World Health Organization Geneva (Switzerland)
33. K.J.R. Murthy, T.R. Frieden, and A. Yazdani Public-private partnership in tuberculosis control: experience in Hyderabad, India Int J Tuberc Lung Dis 5 2001 354 359
34. M.C. Raviglione, C. Dye, and S. Schmidt Assessment of worldwide tuberculosis control Lancet 350 1997 624 629
35. World Health Organization Forty-fourth World Health Assembly. Resolutions and decisions. Resolution WHA 44.8. WHA44/1991/REC/1 1991 World Health Organization Geneva (Switzerland)
36. World Health Organization Fifty-third World Health Assembly. Resolutions and decisions. Resolution WHA 53.1 2000 World Health Organization Geneva (Switzerland)
37. Styblo K., Bumgarner J.R. Tuberculosis can be controlled with existing technologies: evidence. Tuberculosis Surveillance Research Unit Progress Report (The Hague, The Netherlands) 1991;2:60-72
38. C. Dye, and B.G. Williams Criteria for the control of drug-resistant tuberculosis Proc Natl Acad Sci USA 97 2000 8180 8185
39. Stop TB Partnership Annual Report 2001. Document WHO/CDS/STB/2002.17 2001 World Health Organization Geneva (Switzerland)
40. D.B. Young Current tuberculosis vaccine development Clin Infect Dis 30 Suppl 3 2000 S254 S256
41. M.D. Perkins New diagnostics for tuberculosis Int J Tuberc Lung Dis 4 12 2000 S182 S188
42. Centers for Disease Control and Prevention Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations MMWR Morb Mortal Wkly Rep 47 No. RR-20 1998 1 58
43. C.E. Barry III, R.A. Slayden, and A.E. Sampson Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs Biochem Pharmacol 59 2000 221 231
44. World Health Organization Report on DOTS Expansion Working Group meeting, Montreal, Canada, in October 2002 [internal document] 2002 World Health Organization Geneva (Switzerland)
45. World Health Organization Global DOTS expansion plan-progress in TB control in high-burden countries 2001, 1 year after the Amsterdam Ministerial Conference. Document WHO/CDS/TB/2003.312 2001 World Health Organization Geneva (Switzerland)
46. World Health Organization Community contribution to TB care: practice and policy. Document WHO/CDS/TB/2003.312 2003 World Health Organization Geneva (Switzerland)
47. World Health Organization and International Labour Office Guidelines for workplace TB control activities. Document WHO/CDS/TB/2003.323 2003 World Health Organization Geneva (Switzerland)
48. World Health Organization Good practice in legislation and regulations for TB control: an indicator of political will. Document WHO/CDS/TB/2001.290 2001 World Health Organization Geneva (Switzerland)
49. K. Lönnroth, M. Uplekar, and V.K. Arora Public-private mix for improved TB control-what makes it work? Bull World Health Organ 82 8 2004 580 586
50. World Health Organization Report on the meeting of the second ad hoc committee on the TB epidemic. Montreux, Switzerland, 18-19, 2003. Recommendations to Stop TB partners. Document WHO/HTM/STB/2004.28 2004 World Health Organization Geneva (Switzerland)
51. World Health Organization Background document prepared for the meeting of the second ad hoc committee on the TB epidemic. Document WHO/HTM/STB/2004.27 2004 World Health Organization Geneva (Switzerland)